                         SEQUENCE LISTING

<110>  Alios BioPharma, Inc.
 
<120>  Modified Oligonucleotides and Methods of Use

<130>  ALP0057WOPCT1

<150> US 62/646,901
<151> 2018-03-22

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  1
ggacuggacu ggacuggacu                                                   20


<210>  2
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide


<220>
<221>  i2FA
<222>  (3)..(3)

<220>
<221>  i2FA
<222>  (8)..(8)

<220>
<221>  i2FA
<222>  (13)..(13)

<220>
<221>  i2FA
<222>  (18)..(18)

<400>  2
ggacuggacu ggacuggacu                                                   20


<210>  3
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  3
gggcugggcu gggcugggcu                                                   20


